Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen

Clin Chem. 1999 Oct;45(10):1863-5.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Aged
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / diagnosis
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Prostate-Specific Antigen